Review ArticlePerspective
Extracellular Mutations of Protease-Activated Receptor-1 Result in Differential Activation by Thrombin and Thrombin Receptor Agonist Peptide
Brian D. Blackhart, Lily Ruslim-Litrus, Chin-Chun Lu, Veronica L. Alves, Willy Teng, Robert M. Scarborough, Elwood E. Reynolds and Donna Oksenberg
Molecular Pharmacology December 2000, 58 (6) 1178-1187; DOI: https://doi.org/10.1124/mol.58.6.1178
Brian D. Blackhart
COR Therapeutics, Inc., South San Francisco, California
Lily Ruslim-Litrus
COR Therapeutics, Inc., South San Francisco, California
Chin-Chun Lu
COR Therapeutics, Inc., South San Francisco, California
Veronica L. Alves
COR Therapeutics, Inc., South San Francisco, California
Willy Teng
COR Therapeutics, Inc., South San Francisco, California
Robert M. Scarborough
COR Therapeutics, Inc., South San Francisco, California
Elwood E. Reynolds
COR Therapeutics, Inc., South San Francisco, California
Donna Oksenberg
COR Therapeutics, Inc., South San Francisco, California
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Review ArticlePerspective
Extracellular Mutations of Protease-Activated Receptor-1 Result in Differential Activation by Thrombin and Thrombin Receptor Agonist Peptide
Brian D. Blackhart, Lily Ruslim-Litrus, Chin-Chun Lu, Veronica L. Alves, Willy Teng, Robert M. Scarborough, Elwood E. Reynolds and Donna Oksenberg
Molecular Pharmacology December 1, 2000, 58 (6) 1178-1187; DOI: https://doi.org/10.1124/mol.58.6.1178
Review ArticlePerspective
Extracellular Mutations of Protease-Activated Receptor-1 Result in Differential Activation by Thrombin and Thrombin Receptor Agonist Peptide
Brian D. Blackhart, Lily Ruslim-Litrus, Chin-Chun Lu, Veronica L. Alves, Willy Teng, Robert M. Scarborough, Elwood E. Reynolds and Donna Oksenberg
Molecular Pharmacology December 1, 2000, 58 (6) 1178-1187; DOI: https://doi.org/10.1124/mol.58.6.1178
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement